Variant NM_000492.4:c.3872A>G


Variant details:
Name NM_000492.4:c.3872A>G
Protein name NP_000483.3:p.(Gln1291Arg)
Genomic name (hg19) chr7:g.117282646A>G    UCSC    gnomAD
#Exon/intron exon 23
Legacy Name Q1291R
Class disease-causing
Subclass varying clinical consequence
WT sequence AGGAAAGCCTTTGGAGTGATACCAC A GGTGAGCAAAAGGACTTAGCCAGAA
Mutant sequence AGGAAAGCCTTTGGAGTGATACCAC G GGTGAGCAAAAGGACTTAGCCAGAA


External sources:
dbSNP
rs397508621





Modulator FDA approval EMA approval in vitro / ex vivo data clinical data
IVA yesnoyesno
TEZ-IVA yesnoyesno
ELX-TEZ-IVA yesnoyesno


clinical and functional data are provided by Vertex


Pathogenicity predictions:
AGVGD MAPP SIFT PPH2
C35 1e-05 0 0.049
VUS2 VUS5 VUS5 VUS1

Color code:   non disease-causing <   VUS1 <   VUS2 <   VUS3 <   VUS4 <   VUS5 <   disease-causing




No patient found in CFTR-NGS catalogue


3 patients carrying this variant are reported in CFTR-France:

TOTAL NUMBER OF PATIENTS 3
CF 2
CFTR-RD1
  • CBAVD  1



Detailed genotypes:
Phenotype Patient ID Variant status Additional variants
CF 4847heterozygoteCF-causing- Undef
CF 2131heterozygoteCF-causing- Undef
CBAVD 4931heterozygoteVUS3- Undef


Color code:   non disease-causing <   VUS1 <   VUS2 <   VUS3 <   VUS4 <   VUS5 <   disease-causing



            CFTR variants are clustered into five groups:
  • CF-causing: when in trans with another CF-causing mutation, will result in CF.
  • CFTR-RD causing: when in trans with a CF-causing mutation, will result in CFTR-related disorders (CFTR-RD) such as chronic pancreatitis, bronchiectasis, CRS-NP (chronic rhinosinusitis with or without nasal polyposis) or CBAVD (congenital absence of vas deferens), according to Bombieri C et al., 2011.
  • Varying clinical consequence: when in trans with another CF-causing mutation, can either result in CF or in a CFTR-RD.
  • Non disease-causing: when in trans with a CF-causing mutation, will not cause CF, nor CFTR-RD.
  • VUS (Variant of unknown clinical significance): unclassified because of insufficient data.